Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. - Takeda,K.; Yamaguchi,N.; Akiba,H.; Kojima,Y.; Hayakawa,Y.; Tanner,J.E.; Sayers,T.J.; Seki,N.; Okumura,K.; Yagita,H.; Smyth,M.J. (J Exp Med, 2004)